Altrova Health FY26 nine-month net loss widens to C$2.35 million; revenue more than doubled to C$112,000
Reuters2026/08/31 22:37- Altrova Health posted nine-month revenue of CAD 112,000, more than doubled from CAD 15,551 a year earlier.
- Net loss widened to CAD 2.35 million from CAD 1.1 million in the prior-year period.
- Gross margin fell 6.6 percentage points to 55.8%, while gross profit rose to CAD 62,488.
- Loss expansion was driven by a CAD 330,640 non-cash license write-off, plus higher non-cash share-based compensation.
- Management highlighted first meaningful product revenue, ongoing NIRLAB device sales, cross-border uplisting, and lower discretionary costs.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Cang (CANG.US) Q2 total revenue fell about 50% quarter-on-quarter; mined 656 bitcoins
Cango announced its financial results for the second quarter of 2026.
Trump boasts "US economy can grow by 20%", says the Federal Reserve should not raise rates because of this
US President Trump, while announcing an agreement in the Oval Office aimed at lowering prescription drug prices, stated that the US economy could grow at a rate of 14%, 15%, 16%, or even 20%, emphasizing that such rapid growth should not prompt the Federal Reserve to raise interest rates.
Zcash Price Targets $1800 as Privacy Demand Fuels Rally
Cabot CEO Sean Keohane disposes of 134,895 shares for $11.47 million
Crypto prices
More
